Synthesis, purification, and anticancer effect of magnetic Fe₃O₄-loaded poly (lactic-co-glycolic) nanoparticles of the natural drug tetrandrine

References

• Acharya, S. and Sahoo, S.K., 2011. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Advanced drug delivery reviews, 63(3), 170–183.
   PubMed Web of Science ®Google Scholar
• Anwer, M.K., et al., 2016. Development and evaluation of PLGA polymer based nanoparticles of quercetin. International journal of biological macromolecules, 92, 213–219.
   PubMed Web of Science ®Google Scholar
• Anwer, M.K., et al., 2019. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. International journal of nanomedicine, 14, 1587–1595.
   PubMed Web of Science ®Google Scholar
• Bhagya, N. and Chandrashekar, K.R., 2016. Tetrandrine–a molecule of wide bioactivity. Phytochemistry, 125, 5–13.
   PubMed Web of Science ®Google Scholar
• Chen, Z., et al., 2018. Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1alpha/ICAM-1 signaling pathway. Oncology letters, 5, 7433–7437.
   Google Scholar
• Choi, H.S., et al., 2007. Renal clearance of quantum dots. Nature biotechnology, 25(10), 1165–1170.
   PubMed Web of Science ®Google Scholar
• Dunnill, P. and Lilly, M.D., 1974. Letter: purification of enzymes using magnetic bio-affinity materials. Biotechnology and bioengineering, 7, 987–990.
   Web of Science ®Google Scholar
• Ferlay, J., et al., 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer, 5, E359–E386.
   Web of Science ®Google Scholar
• Fischer, H.C. and Chan, W., 2007. Nanotoxicity: the growing need for in vivo study. Current opinion in biotechnology, 6, 565–571.
   Web of Science ®Google Scholar
• Friedrich, J., et al., 2009. Spheroid-based drug screen: considerations and practical approach. Nature protocols, 3, 309–324.
   Web of Science ®Google Scholar
• Goodman, T.T., Ng, C.P., and Pun, S.H., 2008. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjugate chemistry, 19(10), 1951–1959.
   PubMed Web of Science ®Google Scholar
• Gupta, A.K. and Gupta, M., 2005. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26(18), 3995–4021.
   PubMed Web of Science ®Google Scholar
• He, K., et al., 2017. The efficacy assessments of alkylating drugs induced by nano-Fe3O4/CA for curing breast and hepatic cancer. Spectrochimica acta a molecular and biomolecular spectroscopy, 173, 82–86.
   PubMed Web of Science ®Google Scholar
• Ho, L.J., et al., 2004. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell. British journal of pharmacology, 143(7), 919–927.
   PubMed Web of Science ®Google Scholar
• Horisawa, E., et al., 2002. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharmaceutical research, 19(2), 132–139.
   PubMed Web of Science ®Google Scholar
• Hu, F.Q., et al., 2009. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials, 30(36), 6955–6963.
   PubMed Web of Science ®Google Scholar
• Jaattela, M., 2004. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene, 16, 2746–2756.
   Web of Science ®Google Scholar
• Jia, Y., et al., 2012. Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. International journal of nanomedicine, 7, 1697–1708.
   PubMed Web of Science ®Google Scholar
• Jia, Z., et al., 2018a. Isolation and characterization of human mesenchymal stem cells derived from synovial fluid by magnetic-activated cell sorting (MACS). Cell biology international, 42(3), 262–271.
   PubMed Web of Science ®Google Scholar
• Jia, Z., et al., 2018b. Magnetic-activated cell sorting strategies to isolate and purify synovial fluid-derived mesenchymal stem cells from a rabbit model. Journal of visualized experiments, 138, e57466.
   Google Scholar
• Keles, H., et al., 2015. Investigation of factors influencing the hydrolytic degradation of single PLGA microparticles. Polymer degradation and stability, 119, 228–241.
   Web of Science ®Google Scholar
• Kirkegaard, T. and Jaattela, M., 2009. Lysosomal involvement in cell death and cancer. Biochimca et biophysica acta, 4, 746–754.
   Web of Science ®Google Scholar
• Koppolu, B., et al., 2010. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomedicine: nanotechnology, biology, and medicine, 6 (2), 355–361.
   PubMed Web of Science ®Google Scholar
• Kularatne, S.A. and Low, P.S., 2010. Targeting of nanoparticles: folate receptor. Methods in molecular biology, 624, 249–265.
   PubMedGoogle Scholar
• Lee, E.A., et al., 2014. Application of magnetic nanoparticle for controlled tissue assembly and tissue engineering. Archives of pharmacal research, 1, 120–128.
   Web of Science ®Google Scholar
• Lee, J.H., Kim, J.W., and Cheon, J., 2013. Magnetic nanoparticles for multi-imaging and drug delivery. Molecules and cells, 4, 274–284.
   Web of Science ®Google Scholar
• Li, F., et al., 2011. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Colloids surf b biointerfaces, 88(1), 58–62.
   PubMed Web of Science ®Google Scholar
• Lin, Y., et al., 2016. A novel derivative of tetrandrine (H1) induces endoplasmic reticulum stress-mediated apoptosis and prosurvival autophagy in human non-small cell lung cancer cells. Tumor biology, 37(8), 10403–10413.
   PubMedGoogle Scholar
• Liu, C., et al., 2018. Self-nanoemulsifying drug delivery system of tetrandrine for improved bioavailability: physicochemical characterization and pharmacokinetic study. Biomed research international, 2018, 6763057.
   PubMed Web of Science ®Google Scholar
• Liu, T., Liu, X., and Li W, 2016. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget, 26, 40800–40815.
   Google Scholar
• Ma, P., et al., 2009. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. Journal of biomedical nanotechnology, 2, 151–161.
   Web of Science ®Google Scholar
• Makadia, H.K. and Siegel, S.J., 2011. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel), 3(3), 1377–1397.
   PubMed Web of Science ®Google Scholar
• Mangal, S., et al., 2017. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta pharmacologica sinica, 38 (6), 782–797.
   PubMed Web of Science ®Google Scholar
• Mao, S., et al., 2008. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. European journal of pharmaceutics and biopharmaceutics, 2, 214–223.
   Web of Science ®Google Scholar
• Mei, L., et al., 2015. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21. British journal of pharmacology, 172(9), 2232–2245.
   PubMed Web of Science ®Google Scholar
• Mir, M., Ahmed, N., and Rehman, A.U., 2017. Recent applications of PLGA based nanostructures in drug delivery. Colloids surf b biointerfaces, 159, 217–231.
   PubMed Web of Science ®Google Scholar
• Nosrati, H., et al., 2017. New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs). Research on chemical intermediates, 43(12), 7423–7442.
   Web of Science ®Google Scholar
• Nosrati, H., et al., 2018. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Drug development and industrial pharmacy, 6, 886–894.
   Web of Science ®Google Scholar
• Pamula, E. and Menaszek, E., 2008. In vitro and in vivo degradation of poly(L: -lactide-co-glycolide) films and scaffolds. Journal of materials science: materials in medicine, 19 (5), 2063–2070.
   PubMed Web of Science ®Google Scholar
• Perche, F. and Torchilin, V.P., 2012. Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer biology and therapy, 13(12), 1205–1213.
   PubMed Web of Science ®Google Scholar
• Reinhardt, M., Bader, A., and Giri, S., 2015. Devices for stem cell isolation and delivery: current need for drug discovery and cell therapy. Expert review of medical devices, 3, 353–364.
   Web of Science ®Google Scholar
• Salehiabar, M., et al., 2018. Facile synthesis and characterization of L-aspartic acid coated iron oxide magnetic nanoparticles (IONPs) for biomedical applications. Drug research, 5, 280–285.
   Google Scholar
• Semwal, D.K., et al., 2010. The genus Stephania (Menispermaceae): chemical and pharmacological perspectives. Journal of ethnopharmacology, 132(2), 369–383.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2014. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Biomed research international, 2014, 156010.
   PubMed Web of Science ®Google Scholar
• Shen, Y.C., et al., 2001. Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Molecular pharmacology, 60(5), 1083–1090.
   PubMed Web of Science ®Google Scholar
• Shi, C., et al., 2015. Improved delivery of the natural anticancer drug tetrandrine. International Journal of pharmaceutics, 1, 41–51.
   Web of Science ®Google Scholar
• Shi, C., et al., 2016. Inhibition of the cancer-associated TASK 3 channels by magnetically induced thermal release of Tetrandrine from a polymeric drug carrier. Journal of controlled release, 237, 50–60.
   PubMed Web of Science ®Google Scholar
• Shinkai, M., 2002. Functional magnetic particles for medical application. Journal of bioscience and bioengineering, 6, 606–613.
   Web of Science ®Google Scholar
• Wen, Z.M., et al., 2017. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Biochemical and biophysical research communications, 4, 1430–1437.
   Web of Science ®Google Scholar
• Xiao, K., et al., 2011. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials, 32(13), 3435–3446.
   PubMed Web of Science ®Google Scholar
• Xu, H., et al., 2014. An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(epsilon-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. International Journal of nanomedicine, 9, 231–242.
   PubMed Web of Science ®Google Scholar
• Xue, P., et al., 2017. PEGylated polydopamine-coated magnetic nanoparticles for combined targeted chemotherapy and photothermal ablation of tumour cells. Colloids and surfaced B biointerfaces, 160, 11–21.
   PubMed Web of Science ®Google Scholar